For Asia, the best-case scenario is that Trump's tariff threats are more a negotiating tactic than a fait accompli. Indeed, ...
Tandem Diabetes Care (TNDM) delivered earnings and revenue surprises of 16.28% and 9.24%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock ...